Skip to main content
. 2013 Feb 15;15(2):559–570. doi: 10.1208/s12248-013-9463-9

Fig. 5.

Fig. 5

Model-predicted relationships between serum free IgE level and steady-state FEV1 percent predicted (a) and serum free IgE level and steady-state FeNO (b). Solid curves are the mean predictions and areas between two dashed curves are the 90% confidence intervals. The histograms illustrate the mean observed posttreatment serum free IgE distributions in the omalizumab and placebo groups